NYSE: TAKTakeda Pharmaceutical Co Ltd Stock Ownership - Who owns Takeda Pharmaceutical Co?
Insider buying vs selling
Have Takeda Pharmaceutical Co Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when TAK insiders and whales buy or sell their stock.
TAK Shareholders
What type of owners hold Takeda Pharmaceutical Co Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Capital Research Global Investors | 0.84% | 13,404,129 | $198.78M | Institution |
| Morgan Stanley | 0.48% | 7,690,415 | $114.05M | Institution |
| Ubs Group Ag | 0.37% | 5,893,969 | $87.41M | Institution |
| Goldman Sachs Group Inc | 0.31% | 4,953,331 | $73.46M | Institution |
| Fmr LLC | 0.26% | 4,186,946 | $62.09M | Institution |
| Brandes Investment Partners LP | 0.25% | 3,931,803 | $58.31M | Institution |
| Renaissance Technologies LLC | 0.24% | 3,864,600 | $57.31M | Institution |
| Blackrock Inc | 0.21% | 3,307,589 | $49.05M | Institution |
| Toronto Dominion Bank | 0.19% | 3,004,300 | $44.55M | Institution |
| Arrowstreet Capital Limited Partnership | 0.18% | 2,828,778 | $41.95M | Institution |
TAK vs Pharmaceutical Stocks
Takeda Pharmaceutical Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.